Skip to content

Clinical trials

Biliary Tract Neoplasms trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Biliary Tract Neoplasms Country / region: Australia Clear all

30 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20151
20161
20171
20193
20203
20212
20224
20236
20244
20254
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting13
Active, not recruiting6
Completed6
Terminated3
Unknown status2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca5
Bayer2
Eli Lilly and Company2
Merck Sharp & Dohme LLC2
ASLAN Pharmaceuticals1
AbbVie1
Amgen1
Boehringer Ingelheim1
Bristol-Myers Squibb1
Daiichi Sankyo1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Biliary Tract Neoplasms30
Carcinoma, Non-Small-Cell Lung12
Colorectal Neoplasms11
Breast Neoplasms9
Endometrial Neoplasms9
Stomach Neoplasms9
Cholangiocarcinoma8
Ovarian Neoplasms7
Pancreatic Neoplasms7
Gallbladder Neoplasms5

Trials

Showing 51 to 30 of 30. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.